GENEVA, May 6 -- PRELUDE THERAPEUTICS INCORPORATED (175 Innovation BoulevardWilmington, Delaware 19805) filed a patent application (PCT/US2025/052252) for "BRM AND BRG1 TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE" on Oct 23, 2025. With publication no. WO/2026/090411, the details related to the patent application was published on Apr 30, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): BASCH, Corey Howard (5 Yorktown AvenueWest Chester, Pennsylvania 19382), PITIS, Philip (106 Sunrise DriveNorth Wales, Pennsylvania 19454), BUESKING, Andrew (25 Longspur DriveWilmington, Delaware 19808), HO...